Overview and Scope
Blood screening refers to a method of screening blood, plasma, or blood components for transfusion or use in blood products. It is used to screen for antibodies or tumor markers, to seek for disease-causing substances or symptoms, or to evaluate treatment effectiveness.
Sizing and Forecast
The blood screening market size has grown strongly in recent years. It will grow from $2.84 billion in 2023 to $3.13 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increased blood transfusion requirements, rising prevalence of transmissible diseases, government regulations and standards, increasing blood donations and collection, global health concerns and pandemics..
The blood screening market size is expected to see rapid growth in the next few years. It will grow to $4.72 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to healthcare infrastructure development, public health awareness programs, advancements in infectious disease diagnostics, global health concerns and pandemic preparedness.. Major trends in the forecast period include rise in infectious diseases, automation and efficiency, rising blood transfusion demands, focus on transfusion safety, research in pathogen detection..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report
Segmentation & Regional Insights
The blood screening market covered in this report is segmented –
1) By Product: Reagents and Kits, Instruments, Software and Services
2) By Technology: Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)
3) By End User: Blood Banks, Diagnostic Centers and Pathology Labs, Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)
Top 5 Major Players:
- Abbott Laboratories
- Grifols S.A
- Becton Dickinson and Company
- F. Hoffmann-La Roche AG
- bioMérieux S.A
North America was the largest region in the blood screening market in 2023. The regions covered in the blood screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9047&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of infectious diseases is expected to propel the growth of the blood screening market going forward. Blood is commonly analyzed for symptoms of illness by looking for a specific antibody generated against the infectious agent, which aids the medical practitioner in treating infectious diseases and preventing further transmission of infection in patients and disease spread from one to one. For instance, in October 2022, according to the fact sheet published by World Health Organization (WHO), a US-based government agency, approximately 1.6 million persons worldwide passed away from tuberculosis in 2021 (including 187 000 people with HIV). Additionally, in December 2022, according to the fact sheet published by World Health Organization, malaria cases increased from 227 million in 2019 to 241 million, and around 6,27,000 people were predicted to die from malaria in 2020, an increase of 69,000 fatalities over 2019. Therefore, the increase in the prevalence of infectious diseases is driving the growth of the blood screening market.
Key Industry Players
Major companies in the blood screening market are focused on strategic collaboration with major manufacturing companies to strengthen their position in the market. Strategic collaborations empower companies to forge alliances with other firms possessing the necessary expertise to transform their envisioned concepts into tangible realities. For instance, in November 2023, Universal DX, a Spanish-based biotech company, announced a strategic collaboration with Quest Diagnostics, a US-based medical laboratory company and supplier of diagnostic information services, to improve colorectal cancer screening in the US, for which more than 110 million people may be eligible. With this collaboration, Quest intends to carry out and offer clinical laboratory services based on UDX’s advanced colorectal cancer screening blood test, Signal-C, to physicians and patients in the US under the terms of the commercial agreement between UDX and Quest.
The blood screening market report table of contents includes:
1. Executive Summary
2. Blood Screening Market Characteristics
3. Blood Screening Market Trends And Strategies
4. Blood Screening Market – Macro Economic Scenario
5. Global Blood Screening Market Size and Growth
…
31. Global Blood Screening Market Competitive Benchmarking
32. Global Blood Screening Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Blood Screening Market
34. Blood Screening Market Future Outlook and Potential Analysis
35. Appendix
List Of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
….
Table 74: Abbott Laboratories Financial Performance
Table 75: Grifols S.A. Financial Performance
Table 76: Becton Dickinson and Company Financial Performance
Table 77: F. Hoffmann-La Roche AG Financial Performance
Table 78: bioMérieux S.A. Financial Performance
Explore the trending research reports from TBRC:
https://topprnews.com/small-modular-reactor-market-share/
https://topprnews.com/spectrum-analyzers-market-size/
https://topprnews.com/active-protection-systems-market-share/
https://goodprnews.com/small-modular-reactor-market-share/
https://goodprnews.com/spectrum-analyzers-market-size/
https://goodprnews.com/active-protection-systems-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
